Key result
Portuguese Delphi panel reaches ~92% consensus emphasizing autonomous research centers and standardized clinical trial conditions.
Why the study?
Despite progress in regulatory alignment and digital tools, clinical research in Portugal faces challenges including limited funding, slow patient recruitment, and regulatory delays.
A nationwide Delphi study in Portugal identified key areas of consensus for improving clinical research practices, particularly regarding research center organization and trial implementation conditions.
Answers are grounded in this paper and cite their sources.
Supports expert consensus for integrated trial centers in Portugal; leaves open effects on enrollment and quality.
Introduction Over the past decades, clinical research has evolved significantly, driven by advances in regulatory frameworks, technological innovations, and methodological approaches. In Portugal, while there has been progress - such as increased regulatory alignment with European standards and the adoption of digital trial management tools - various challenges remain. These may include, among others, limited access to funding, slower patient recruitment rates, and regulatory hurdles that can delay trial approvals. Our goal was to identify key areas for improvement toward the optimization of clinical research practices in the country. Methods A modified three-round Delphi study was conducted online (2023-2024) to achieve a nationwide expert consensus. The scientific committee, composed of seven experts, developed 45 initial statements across five topics: dedication time to clinical research, organization of integrated research centers, conditions for implementing clinical trials, the role of institutional authorities, and patient recruitment and referral. A five-point Likert-type scale was used (1 - 'strongly disagree', 2 - 'disagree', 3 - 'neither agree nor disagree', 4 - 'agree', and 5 - 'strongly agree') to rate each statement. The consensus threshold was established as a percentage of agreement among participants (≥90% in the first round and ≥85% in the second round). The level of consensus achieved by the panel was discussed by the scientific committee during virtual meetings. Results Fifty-one experts completed the exercise (86.4% response rate). Consensus was reached on 32 of the 45 initial statements (71.1%) in the first round, with most of them (n = 20, or 62.5%) presenting high concordance rates (>95%). Four new statements were added for the second round, grounded on the feedback from the experts. By the end of the study, consensus was achieved on 45 out of the 49 final statements (91.8%), with the greatest agreement on the organization of integrated research centers and conditions for implementing clinical trials. Three statements regarding patient recruitment and referral, and one statement on the role of institutional authorities to promote clinical research, did not reach consensus, highlighting the need for further dialogue and innovative solutions in these fields. Conclusion The insights of this study can inform health organizations, regulatory agencies, and other stakeholders about the barriers and opportunities to improve clinical research in Portugal. By learning from global best practices and tailoring strategies to local contexts, the country can become a more prominent player in the international community.
No takes yet. Share an insight, caveat, or question.
Resende et al. (2024) studied Clinical research practices (n=51). Delphi questionnaire on clinical research practices was evaluated on Consensus on statements regarding clinical research practices (≥90% agreement in round 1, ≥85% in round 2). A nationwide Delphi panel of experts reached consensus on 45 of 49 statements, emphasizing the need for autonomous integrated research centers and standardized conditions for clinical trials in Portugal.
Synapse has enriched 10 related papers. Consider them for comparative context: